Travere Therapeutics to Present at the BofA Securities 2022 Healthcare Conference

Rhea-AI Summary

SAN DIEGO, May 3, 2022 (GLOBE NEWSWIRE) - Travere Therapeutics (NASDAQ: TVTX) announced that CEO Eric Dube, Ph.D., will present at the BofA Securities 2022 Healthcare Conference on May 10, 2022, at 4:00 p.m. PT. A live webcast of the presentation will be available, along with an archived replay accessible for 30 days post-event.

Travere Therapeutics focuses on developing therapies for patients with rare diseases, emphasizing the need for urgent treatment options and collaboration with the rare disease community.

SAN DIEGO, May 03, 2022 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that Eric Dube, Ph.D., president and chief executive officer, will present at the BofA Securities 2022 Healthcare Conference on Tuesday, May 10, 2022, at 4:00 p.m. PT.

A live webcast will be available at https://ir.travere.com/events-presentations and an archived replay will be accessible for up to 30 days.

About Travere Therapeutics

At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com

Contact:
Chris Cline, CFA                                 
Senior Vice President, Investor Relations & Corporate Communications
888-969-7879                                        
IR@travere.com    

FAQ

When will Travere Therapeutics present at the BofA Securities Healthcare Conference?

Travere Therapeutics will present on May 10, 2022, at 4:00 p.m. PT.

Who is presenting for Travere Therapeutics at the conference?

Eric Dube, Ph.D., the CEO of Travere Therapeutics, will present.

Where can I watch the Travere Therapeutics conference presentation?

The presentation will be available via a live webcast at Travere's investor relations website.

How long will the presentation from Travere Therapeutics be available after the event?

An archived replay of the presentation will be accessible for 30 days.

What is the focus of Travere Therapeutics?

Travere Therapeutics specializes in developing therapies for rare diseases.